-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Science and Technology Daily (Reporter Dong Yingbi) A research team composed of three scientific research institutions including Tomsk University of Technology in Russia has developed a new method for imaging cancer tumor metastases.
Modern medicine has found that it is easier to treat cancer in the early stages, and the primary tumor can be removed or radiotherapy can be applied to it
A research team composed of Tomsk University of Technology, the Seminyakin and Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, and the Tomsk National Research Medical Center of the Russian Academy of Sciences have developed pharmaceutical substances for personalized treatment , Especially found the radionuclide for target imaging for the treatment of tumor diseases
However, compared with the pharmaceutical substances developed by Tomsk University of Technology, EpCAM drugs usually contain severe toxins or cytotoxic compounds, which may cause serious adverse reactions in patients
According to Vladimir Tolmachev, director of the Oncology Research Center of Tomsk University of Technology, the proteins are labeled with radionuclides, which can identify therapeutic targets
Vladimir Tolmachev said that the targets that researchers are studying exist in pancreatic cancer, ovarian cancer, prostate cancer and other diseases.